RB1 and prostate cancer: These seemingly contradictory findings might begin to explain how E2F1 functions in a more traditional role to activate AR in the absence of RB in prostate cancer cells, yet represses AR transcription in normal (non-transformed and non-immortalized) prostate epithelium in the context of functional RB.